Suppr超能文献

抑郁症患者垂体对促甲状腺激素释放激素的反应:综述

Pituitary responses to thyrotropin releasing hormone in depressed patients: a review.

作者信息

Loosen P T, Prange A J, Wilson I C, Lara P P

出版信息

Pharmacol Biochem Behav. 1976;5(Suppl 1):95-101. doi: 10.1016/0091-3057(76)90335-x.

Abstract

Numerous studies show that most depressed patients show abnormal pituitary responses to challenge by intravenous injection of thyrotropin releasing hormone (TRH). Some patients show after TRH diminished thyroid stimulating hormone (TSH) release, some show unexpected growth hormone release; prolactin release may be increased or decreased. The diminished TSH release is the most widely reported finding. It cannot be accounted for by primary changes in the pituitary or thyroid glands. Interference with TRH-induced TSH release by elevated cortisol may account for some observations, but this possibility has not been studied. The present data provide additional evidence that in depression there is often a disruption of hypothalamic regulatory function.

摘要

大量研究表明,大多数抑郁症患者在静脉注射促甲状腺激素释放激素(TRH)进行激发试验时,垂体反应异常。一些患者在注射TRH后促甲状腺激素(TSH)释放减少,一些患者出现意外的生长激素释放;催乳素释放可能增加或减少。TSH释放减少是报道最为广泛的发现。这不能用垂体或甲状腺的原发性改变来解释。皮质醇升高对TRH诱导的TSH释放的干扰可能解释了一些观察结果,但这种可能性尚未得到研究。目前的数据提供了更多证据,表明抑郁症患者下丘脑调节功能常遭破坏。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验